相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Josep M. Llovet et al.
HEPATOLOGY (2021)
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
Tae Hyun Kim et al.
JOURNAL OF HEPATOLOGY (2021)
IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) plus bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC).
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States
Nicole E. Rich et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
Jiajie Hou et al.
JOURNAL OF HEPATOLOGY (2020)
Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis
Giammauro Berardi et al.
JOURNAL OF HEPATOLOGY (2020)
The chances of hepatic resection curing hepatocellular carcinoma
Alessandro Cucchetti et al.
JOURNAL OF HEPATOLOGY (2020)
Adaptive immunity: an emerging player in the progression of NAFLD
Salvatore Sutti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma A Randomized Clinical Trial
Yong Xia et al.
JAMA ONCOLOGY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2020)
Novel patient-derived preclinical models of liver cancer
Erin Bresnahan et al.
JOURNAL OF HEPATOLOGY (2020)
mRECIST for HCC: Performance and novel refinements
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2020)
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs
Anita Paisant et al.
JOURNAL OF HEPATOLOGY (2020)
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Natural history of NASH and HCC
Francesco Negro
LIVER INTERNATIONAL (2020)
B cells to the forefront of immunotherapy
Tullia C. Bruno
NATURE (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Impact of Anatomical Resection for Hepatocellular Carcinoma With Microportal Invasion (vp1) A Multi-institutional Study by the Kyushu Study Group of Liver Surgery
Masaaki Hidaka et al.
ANNALS OF SURGERY (2020)
Prognostic value of programmed cell death ligand (PD-L1) for hepatocellular carcinoma: a meta-analysis
Xiao-Song Li et al.
BIOSCIENCE REPORTS (2020)
Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC).
Robin Kate Kelley et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
Alessandro Cucchetti et al.
JOURNAL OF HEPATOLOGY (2020)
The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
Elliot B. Tapper et al.
JOURNAL OF HEPATOLOGY (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials
Emmett V. Schmidt et al.
JAMA NETWORK OPEN (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma
Nicole E. Rich et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol et al.
GUT (2019)
Impaired brain glymphatic flow in experimental hepatic encephalopathy
Anna Hadjihambi et al.
JOURNAL OF HEPATOLOGY (2019)
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2019)
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Michael Teufel et al.
GASTROENTEROLOGY (2019)
Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT).
Masatoshi Kudo et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
Chunfeng Qu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The Intersection between Tumor Angiogenesis and Immune Suppression
Osama E. Rahma et al.
CLINICAL CANCER RESEARCH (2019)
A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
Namiki Izumi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir et al.
NATURE MEDICINE (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
Robert Montal et al.
BRITISH JOURNAL OF CANCER (2019)
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents
Agrin Moeini et al.
GASTROENTEROLOGY (2019)
Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
George N. Ioannou et al.
GASTROENTEROLOGY (2019)
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma
Po-Chien Shen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Anand Rotte
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2019)
Molecular and histological correlations in liver cancer
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2019)
The role of telomeres and telomerase in cirrhosis and liver cancer
Jean-Charles Nault et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke et al.
JOURNAL OF HEPATOLOGY (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma
Richard D. Kim et al.
CANCER DISCOVERY (2019)
LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
T Yau et al.
ANNALS OF ONCOLOGY (2019)
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
Bettina Langhans et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Image-Guided Percutaneous Microwave Ablation Versus Cryoablation For Hepatocellular Carcinoma In High-Risk Locations: Intermediate-Term Results
Jiahui Hu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?
Mark A. Febbraio et al.
CELL METABOLISM (2019)
Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review
Christian B. van der Pol et al.
GASTROENTEROLOGY (2019)
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
Joong-Won Park et al.
JOURNAL OF HEPATOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
Paulo Bergerot et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautes-Fridman et al.
NATURE REVIEWS CANCER (2019)
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Marc Puigvehi et al.
JHEP REPORTS (2019)
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis
Laura Kulik et al.
HEPATOLOGY (2018)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study
Ian Chau et al.
BRITISH JOURNAL OF CANCER (2018)
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
Roberta Zappasodi et al.
CANCER CELL (2018)
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
Ho Yeong Lim et al.
CLINICAL CANCER RESEARCH (2018)
A long-term experience with expansion of Milan criteria for liver transplant recipients
Sarah Jane Commander et al.
CLINICAL TRANSPLANTATION (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clinical states of cirrhosis and competing risks
Gennaro D'Amico et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Lorenza Rimassa et al.
LANCET ONCOLOGY (2018)
The immunology of hepatocellular carcinoma
Marc Ringelhan et al.
NATURE IMMUNOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Ismail Labgaa et al.
ONCOGENE (2018)
Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis
Xiao-Lin Xu et al.
RADIOLOGY (2018)
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells
Chi Ma et al.
SCIENCE (2018)
Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target
Dabin Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests
Gonzalo Torga et al.
JAMA ONCOLOGY (2018)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Vogel et al.
ANNALS OF ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Necroptosis microenvironment directs lineage commitment in liver cancer
Marco Seehawer et al.
NATURE (2018)
Neighbourhood deaths switch cancer subtype
Eli Pikarsky
NATURE (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Is it Time to Abandon the Milan Criteria? Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies
Karim J. Halazun et al.
ANNALS OF SURGERY (2018)
Radiofrequency Ablation vs. Cryoablation for Localized Hepatocellular Carcinoma: A Propensity-matched Population Study
Jimmy Xu et al.
ANTICANCER RESEARCH (2018)
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Marcus Grohmann et al.
CELL (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
Quentin Bayard et al.
NATURE COMMUNICATIONS (2018)
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Masatoshi Kudo et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions
Won Young Tak et al.
CLINICAL CANCER RESEARCH (2018)
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
Marta Garnelo et al.
GUT (2017)
Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
Jie Yu et al.
GUT (2017)
An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
Omair Atiq et al.
HEPATOLOGY (2017)
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2017)
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
Riccardo Lencioni et al.
JOURNAL OF HEPATOLOGY (2017)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
David J. Pinato et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Reem Waziry et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib
Tim Meyer et al.
LIVER INTERNATIONAL (2017)
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Shabnam Shalapour et al.
NATURE (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
Olivier Sutter et al.
RADIOLOGY (2017)
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Alvin W. T. Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
Eric Letouze et al.
NATURE COMMUNICATIONS (2017)
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015
Tomi Akinyemiju et al.
JAMA ONCOLOGY (2017)
Combination immunotherapy: a road map
Patrick A. Ott et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
mTORC2 Promotes Tumorigenesis via Lipid Synthesis
Yakir Guri et al.
CANCER CELL (2017)
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma
K. K. C. Ng et al.
BRITISH JOURNAL OF SURGERY (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng et al.
CELL (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS
Detian Yuan et al.
CANCER CELL (2017)
Hepatocellular carcinoma: Mouse models and the potential roles of proteases
James M. Henderson et al.
CANCER LETTERS (2017)
Implementing Genome-Driven Oncology
David M. Hyman et al.
CELL (2017)
p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells
Atsushi Umemura et al.
CANCER CELL (2016)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
Iris Martinez-Quetglas et al.
GASTROENTEROLOGY (2016)
Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
Mei-Hwei Chang et al.
GASTROENTEROLOGY (2016)
Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data
Riccardo Lencioni et al.
HEPATOLOGY (2016)
Prospective Validation of Ab Initio Liver Transplantation in Hepatocellular Carcinoma Upon Detection of Risk Factors for Recurrence After Resection
Joana Ferrer-Fabrega et al.
HEPATOLOGY (2016)
Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study
Fabio Piscaglia et al.
HEPATOLOGY (2016)
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S. Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Daniel R. Wahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease
Naoshi Nishida et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
Takashi Kokudo et al.
JOURNAL OF HEPATOLOGY (2016)
Alpha-fetoprotein and 18F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation
Geun Hong et al.
JOURNAL OF HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Riccardo Lencioni et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Chi Ma et al.
NATURE (2016)
LIVER CANCER Effect of HCV clearance with direct-acting antiviral agents on HCC
Josep M. Llovet et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K. Geissler et al.
TRANSPLANTATION (2016)
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
Davide Citterio et al.
JAMA SURGERY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Recurrence of Hepatocellular Cancer After Resection Patterns, Treatments, and Prognosis
Parissa Tabrizian et al.
ANNALS OF SURGERY (2015)
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges
Chi-Ping Day et al.
CELL (2015)
Global Epidemiology of Hepatocellular Carcinoma An Emphasis on Demographic and Regional Variability
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2015)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
Francis Y. Yao et al.
HEPATOLOGY (2015)
The role of hepatic resection in the treatment of hepatocellular cancer
Sasan Roayaie et al.
HEPATOLOGY (2015)
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
Jean-Claude Trinchet et al.
HEPATOLOGY (2015)
Multicenter Randomized Controlled Trial of Percutaneous Cryoablation Versus Radiofrequency Ablation in Hepatocellular Carcinoma
Chunping Wang et al.
HEPATOLOGY (2015)
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial
Giovan Giuseppe Di Costanzo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
Luca Vigano et al.
JOURNAL OF HEPATOLOGY (2015)
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
Alessandro Vitale et al.
JOURNAL OF HEPATOLOGY (2015)
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
Oriana Miltiadous et al.
JOURNAL OF HEPATOLOGY (2015)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis
Rex G. Cheng et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
Stephan Buch et al.
NATURE GENETICS (2015)
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas
Jean-Charles Nault et al.
NATURE GENETICS (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
Shlomi Finkin et al.
NATURE IMMUNOLOGY (2015)
Image-guided ablation of primary liver and renal tumours
David J. Breen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
Margit Hagel et al.
CANCER DISCOVERY (2015)
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
Bruno Vincenzi et al.
PLOS ONE (2015)
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Hayato Nakagawa et al.
CANCER CELL (2014)
Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Monika Julia Wolf et al.
CANCER CELL (2014)
Inhibition of De Novo NAD+ Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
Krishna S. Tummala et al.
CANCER CELL (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Brivanib as Adjuvant Therapy to Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Randomized Phase III Trial
Masatoshi Kudo et al.
HEPATOLOGY (2014)
Immunodominance and Functional Alterations of Tumor-Associated Antigen-Specific CD8+ T-Cell Responses in Hepatocellular Carcinoma
Tobias Flecken et al.
HEPATOLOGY (2014)
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib The EVOLVE-1 Randomized Clinical Trial
Andrew X. Zhu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
Lei Yin et al.
JOURNAL OF HEPATOLOGY (2014)
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
Ramona Rudalska et al.
NATURE MEDICINE (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Actual 10-year survival following hepatectomy for hepatocellular carcinoma
Bernardo Franssen et al.
HPB (2014)
Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
Elad Horwitz et al.
CANCER DISCOVERY (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Tania M. Welzel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Resection of Hepatocellular Carcinoma with Macroscopic Vascular Invasion
Sasan Roayaie et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
New Data Supporting Modified RECIST (mRECIST) for Hepatocellular Carcinoma
Riccardo Lencioni
CLINICAL CANCER RESEARCH (2013)
Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis
Francesca Bravi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Prognostic Gene Expression Signature for Patients With Hepatitis C-Related Early-Stage Cirrhosis
Yujin Hoshida et al.
GASTROENTEROLOGY (2013)
Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
Sasan Roayaie et al.
HEPATOLOGY (2013)
Yttrium-90 Radioembolization for Intermediate-Advanced Hepatocellular Carcinoma: A Phase 2 Study
Vincenzo Mazzaferro et al.
HEPATOLOGY (2013)
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
Zhen-Wei Peng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
Jianhua Yin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma
Alexis Bujold et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma
Momar Diouf et al.
JOURNAL OF HEPATOLOGY (2013)
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
Chih-Wen Lin et al.
JOURNAL OF HEPATOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort
L. M. Kulik et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis A Danish Nationwide Cohort Study
Peter Jepsen et al.
ANNALS OF INTERNAL MEDICINE (2012)
Screening for Liver Cancer: The Rush to Judgment
Frank A. Lederle et al.
ANNALS OF INTERNAL MEDICINE (2012)
Resection of Hepatocellular Carcinoma Without Cirrhosis
Brian Shrager et al.
ANNALS OF SURGERY (2012)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
Anja Lachenmayer et al.
CLINICAL CANCER RESEARCH (2012)
Predictive in vivo animal models and translation to clinical trials
Natalie Cook et al.
DRUG DISCOVERY TODAY (2012)
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
Carlo Schneider et al.
GUT (2012)
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
Marta Burrel et al.
JOURNAL OF HEPATOLOGY (2012)
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
Mallika Singh et al.
NATURE BIOTECHNOLOGY (2012)
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cecile Guichard et al.
NATURE GENETICS (2012)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
Masatoshi Kudo et al.
EUROPEAN JOURNAL OF CANCER (2011)
Ultrasonographic Surveillance of Hepatocellular Carcinoma in Cirrhosis: A Randomized Trial Comparing 3-and 6-Month Periodicities
Jean-Claude Trinchet et al.
HEPATOLOGY (2011)
Feasibility of Conducting a Randomized Control Trial for Liver Cancer Screening: Is a Randomized Controlled Trial for Liver Cancer Screening Feasible or Still Needed?
Hossein Poustchi et al.
HEPATOLOGY (2011)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Tae-Won Kang et al.
NATURE (2011)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Health-Related Quality of Life in Patients With Hepatocellular Carcinoma: A Systematic Review
Sheng-Yu Fan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
Riad Salem et al.
GASTROENTEROLOGY (2010)
Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival
Philip Hilgard et al.
HEPATOLOGY (2010)
Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: Evidence from an updated meta-analysis
Bin Wang et al.
JOURNAL OF HEPATOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
The Liver as a Lymphoid Organ
Ian Nicholas Crispe
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Pathologic Diagnosis of Early Hepatocellular Carcinoma: A Report of the International Consensus Group for Hepatocellular Neoplasia
Masamichi Kojiro et al.
HEPATOLOGY (2009)
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer
Yuan-Chin Amy Lee et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2009)
Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial
Takuji Okusaka et al.
JOURNAL OF HEPATOLOGY (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria
M. Ravaioli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
Derek Y. Chiang et al.
CANCER RESEARCH (2008)
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis
Karin L. Andersson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma
Takeaki Ishizawa et al.
GASTROENTEROLOGY (2008)
Experimental models of hepatocellular carcinoma
Philippa Newell et al.
JOURNAL OF HEPATOLOGY (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
Alejandro Forner et al.
HEPATOLOGY (2008)
Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-Expanded criteria based on preoperative imaging
F. Y. Yao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Chemoembolization of hepatocellular carcinoma with drug eluting beads:: Efficacy and doxorubicin pharmacokinetics
Maria Varela et al.
JOURNAL OF HEPATOLOGY (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma - A prospective randomized trial
Ming Shi et al.
ANNALS OF SURGERY (2007)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
Science and society - How participants in cancer trials are chosen: ethics and conflicting interests
G Jayson et al.
NATURE REVIEWS CANCER (2006)
Model organisms - The mighty mouse: genetically engineered mouse models in cancer drug development
Norman E. Sharpless et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Cirrhotic nodules: Association between MR Imaging signal intensity and intranodular blood supply
R Shinmura et al.
RADIOLOGY (2005)
A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma
S Shiina et al.
GASTROENTEROLOGY (2005)
Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation
R Lencioni et al.
RADIOLOGY (2005)
Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma
M Sala et al.
HEPATOLOGY (2004)
Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4cm
SM Lin et al.
GASTROENTEROLOGY (2004)
Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18
JM Blazeby et al.
EUROPEAN JOURNAL OF CANCER (2004)
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
MC Kew
LIVER INTERNATIONAL (2003)
Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection
RA Lencioni et al.
RADIOLOGY (2003)
Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene
P Paterlini-Bréchot et al.
ONCOGENE (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Measuring health-related quality of life in patients with hepatobiliary cancers: The functional assessment of cancer therapy-hepatobiliary questionnaire
N Heffernan et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease
AL Fracanzani et al.
HEPATOLOGY (2001)
分享论文
